Keyword: Vaccines


Moderna Chooses Oxfordshire Site for UK Tech Center

07.03.2023 -

US vaccine maker Moderna has chosen the Harwell Science Campus in Oxfordshire, England, as the location for its planned UK Innovation and Technology Center which is...


CureVac Presents Positive Data from mRNA Trials

01.02.2023 -

German biotech CureVac has released preliminary data from its ongoing cooperation with UK drugmaker GSK on a new class of “transformative medicines” based on messenger...


J&J Ends Mosaico HIV Vaccine Trial on poor Results

27.01.2023 -

Johnson & Johnson’s pharmaceuticals subsidiary Janssen is walking away from plans to launch an HIV vaccine in the immediate future after the data safety monitoring board...


Resilience and Mubadala in Biopharma Venture

17.01.2023 -

US biopharma manufacturing and technology company National Resilience has entered into an agreement with Abu Dhabi investor Mubadala Investment Company to build a...


BioNTech to Acquire all of InstaDeep

16.01.2023 -

As it continues to leverage earnings from its top-selling mRNA-based Covid vaccine to deepen its existing knowhow, Mainz, Germany-based BioNtech has announced plans to...


FDA Approves Omicron-targeted Children’s Vaccines

21.12.2022 -

The US Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUAs) for the updated Covid-19 vaccines of both Pfizer/BioNTech and Moderna in children...


Pfizer Files Rebuttal of Moderna’s Patent Claim

08.12.2022 -

Faced with a lawsuit from US rival Moderna, alleging that Pfizer and its German partner BioNTech infringed one of its patent for their top-selling Covid-19 vaccine...


AstraZeneca Sells US Site to National Resilience

07.12.2022 -

Two weeks after annnouncing that it would no longer seek to market its Covid-19 vaccine in the US, Anglo-Swedish drugmaker AstraZeneca has unveiled plans to sell its...